Stefan-Erik von Euw
Direktor/Vorstandsmitglied bei NovaHep AB
Profil
Stefan-Erik von Euw is currently a Director at NovaHep AB.
Previously, he was a Director at Recopharma AB and a Managing Partner at Alden Impact Capital AG from 2011 to 2017.
Aktive Positionen von Stefan-Erik von Euw
| Unternehmen | Position | Beginn |
|---|---|---|
NovaHep AB
 NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stefan-Erik von Euw
| Unternehmen | Position | Ende |
|---|---|---|
Alden Impact Capital AG
 Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011. | Private Equity Investor | 31.12.2017 |
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Alden Impact Capital AG
Alden Impact Capital AG Investment ManagersFinance Alden Impact Capital AG is a private equity firm with headquarters in Zurich. It was founded in 2011. | Finance |
Recopharma AB
Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
